ASX:AT1Health Care Equipment & ServicesHealth Care Equipment

ATOMO DIAGNOSTICS ORD

$0.034
+$0.003 (+8.11%)
Day Range
$0.034 - $0.036
52 Week Range
$0.014 - $0.043
Volume
1.58M
Avg Volume (10D)
2.18M
Market Cap
$27.55M
Price Chart
Market Statistics
Open$0.036
Previous Close$0.037
Day High$0.036
Day Low$0.034
52 Week High$0.043
52 Week Low$0.014
Valuation
Market Cap27.55M
Shares Outstanding810.18M
Price to Book3.92
Trading Activity
Volume1.58M
Value Traded54.98K
Bid$0.034 × 33,510
Ask$0.038 × 27,121
Performance
1 Day-7.50%
5 Day12.12%
13 Week76.19%
52 Week94.74%
YTD94.74%
Technical Indicators
RSI (14)53.34
50-Day SMA$0.029
200-Day SMA$0.021
Latest News
Atomo Diagnostics to supply HIV test kits across SA and Victoria as part of national vending machine program
Biotechnology

Atomo Diagnostics to supply HIV test kits across SA and Victoria as part of national vending machine program

Atomo Diagnostics (ASX: AT1) has received a $230,000 order from Thorne Harbour Health for HIV Self Test kits to support a national scale-up of the federal government’s CONNECT program, which provides free kits through vending machines. Thorne’s order will supply kits to machines across South Australia and Victoria as part of the government’s pilot program […]

2 min read
Imelda Cotton
Imelda Cotton
Weekly wrap: WiseTech relief rally helps market to bounce higher
Hot Topics

Weekly wrap: WiseTech relief rally helps market to bounce higher

After days of fairly salacious headlines around WiseTech founder Richard White and his penchant for delivering mansions to girlfriends, the company pushed the entire Australian market into making a small gain. News that Mr White would step aside as chief executive but will return in a full-time product and business development consulting role led to […]

6 min read
John Beveridge
John Beveridge
Atomo Diagnostics secures $2.44m grant to develop first rapid active syphilis self-test
Biotechnology

Atomo Diagnostics secures $2.44m grant to develop first rapid active syphilis self-test

Atomo Diagnostics (ASX: AT1) has again been recognised by the Australian government with the award of a $2.44 million grant to develop a unique syphilis test. The Australian-based medical device company was awarded the CRC-P industry grant from the Department of Industry, Science and Resources (DISR) to support the development of an innovative rapid active […]

2 min read
Colin Hay
Colin Hay
Atomo Diagnostics boosted by federal funding for HIV prevention and self-test expansion
Biotechnology

Atomo Diagnostics boosted by federal funding for HIV prevention and self-test expansion

Medical device company Atomo Diagnostics (ASX: AT1) has welcomed the Australian government’s commitment to fund the expansion of self-testing procedures for human immunodeficiency virus (HIV) in this week’s federal budget. The company anticipates that a significant portion of the $43.9 million committed to HIV prevention will be used for the procurement of more of its […]

1 min read
Imelda Cotton
Imelda Cotton